Correlation Between Hepion Pharmaceuticals and Zura Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Zura Bio Limited, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Zura Bio.

Diversification Opportunities for Hepion Pharmaceuticals and Zura Bio

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Hepion and Zura is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Zura Bio go up and down completely randomly.

Pair Corralation between Hepion Pharmaceuticals and Zura Bio

Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to under-perform the Zura Bio. In addition to that, Hepion Pharmaceuticals is 4.24 times more volatile than Zura Bio Limited. It trades about -0.11 of its total potential returns per unit of risk. Zura Bio Limited is currently generating about -0.11 per unit of volatility. If you would invest  177.00  in Zura Bio Limited on November 18, 2024 and sell it today you would lose (22.00) from holding Zura Bio Limited or give up 12.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Hepion Pharmaceuticals  vs.  Zura Bio Limited

 Performance 
       Timeline  
Hepion Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Zura Bio Limited 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zura Bio Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Hepion Pharmaceuticals and Zura Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hepion Pharmaceuticals and Zura Bio

The main advantage of trading using opposite Hepion Pharmaceuticals and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.
The idea behind Hepion Pharmaceuticals and Zura Bio Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm